Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.08 USD | +5.00% | +17.45% | +714.97% |
04-11 | Sector Update: Health Care Stocks Decline Thursday Afternoon | MT |
04-11 | Candel Therapeutics Shares Rise After FDA Orphan Drug Designation for Potential Pancreatic Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+714.97% | 337M | |
+41.50% | 50.93B | |
-0.39% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.89% | 26.02B | |
-21.94% | 18.9B | |
+7.45% | 13.21B | |
+24.36% | 12.17B | |
+30.23% | 12.16B |
- Stock Market
- Equities
- CADL Stock
- News Candel Therapeutics, Inc.
- Candel Therapeutics Shares Surge Premarket Following 'Positive' Phase 2 Results From Non-Metastatic Pancreatic Cancer Trial